ABSTRACT
The African Great Lakes region including Eastern Democratic Republic of the Congo is a hotspot for cholera transmission. We evaluated the local and global clustering of cholera using 5 years (2016—2020) of suspected cases positive by rapid diagnostic test in Uvira, South Kivu to detect spatiotemporal clusters and the extent of zones of increased risk around cases. We detected 26 clusters (mean radius 652m and mean duration 24.8 days) which recurred annually in three locations and typically preceded seasonal outbreaks. We found a 1100m zone of increased infection risk around cases during the 5 days following clinic attendance for the 2016—2020 period and a 600m radius risk zone for 2020 alone. These risk zone sizes correspond with the area typically used for targeted intervention in the Democratic Republic of the Congo. Our findings underscore the value of the site-specific evaluation of clustering to guide targeted control efforts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
RR is funded by a Doctoral Foreign Study Award from the Canadian Institutes of Health Research (Award no. DFS-164266 to RR). The trial on which this study sources its data was co-funded by the French Agency for Development (Ref. No. EVA/364-2015) and the Veolia Foundation (Ref. No. 13/14 HD 1123).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The London School of Hygiene and Tropical Medicine Ethics Review Board gave ethical approval for this work (Ref #10603-5). The University of Kinshasa School of Public Health Ethics Review Board gave ethical approval for this work (Ref #ESP/CE/173B/2022).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
